LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]
Wang Y, Wang X, Han L, Hu D. Cancer Manag Res. 2020;12:9999–10010. At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors raised concerns over similarities between the flow cytometry data provided in Figures 2,...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-lncrna-malat1-regulates-the-progression-and-cisplatin-resis-peer-reviewed-fulltext-article-CMAR |
_version_ | 1811197458906087424 |
---|---|
author | Wang Y Wang X Han L Hu D |
author_facet | Wang Y Wang X Han L Hu D |
author_sort | Wang Y |
collection | DOAJ |
description | Wang Y, Wang X, Han L, Hu D. Cancer Manag Res. 2020;12:9999–10010.
At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors raised concerns over similarities between the flow cytometry data provided in Figures 2, 4 and 7 and indicated that it may have been fabricated. In addition, the authors advised that the cell migration and invasion data also provided in Figures 2, 4 and 7 was unreliable. The authors were unable to provide original data for their study and could not verify the reported findings. The Editor agreed with the authors decision to retract the article.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. |
first_indexed | 2024-04-12T01:15:10Z |
format | Article |
id | doaj.art-2551a03d65f04bf3a288467ac1cb06a6 |
institution | Directory Open Access Journal |
issn | 1179-1322 |
language | English |
last_indexed | 2024-04-12T01:15:10Z |
publishDate | 2022-12-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Cancer Management and Research |
spelling | doaj.art-2551a03d65f04bf3a288467ac1cb06a62022-12-22T03:54:00ZengDove Medical PressCancer Management and Research1179-13222022-12-01Volume 143457345880359LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]Wang YWang XHan LHu DWang Y, Wang X, Han L, Hu D. Cancer Manag Res. 2020;12:9999–10010. At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors raised concerns over similarities between the flow cytometry data provided in Figures 2, 4 and 7 and indicated that it may have been fabricated. In addition, the authors advised that the cell migration and invasion data also provided in Figures 2, 4 and 7 was unreliable. The authors were unable to provide original data for their study and could not verify the reported findings. The Editor agreed with the authors decision to retract the article. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.https://www.dovepress.com/retraction-lncrna-malat1-regulates-the-progression-and-cisplatin-resis-peer-reviewed-fulltext-article-CMARovarian cancermalat1mir-1271-5pe2f5cisplatin |
spellingShingle | Wang Y Wang X Han L Hu D LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction] Cancer Management and Research ovarian cancer malat1 mir-1271-5p e2f5 cisplatin |
title | LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction] |
title_full | LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction] |
title_fullStr | LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction] |
title_full_unstemmed | LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction] |
title_short | LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction] |
title_sort | lncrna malat1 regulates the progression and cisplatin resistance of ovarian cancer cells via modulating mir 1271 5p e2f5 axis retraction |
topic | ovarian cancer malat1 mir-1271-5p e2f5 cisplatin |
url | https://www.dovepress.com/retraction-lncrna-malat1-regulates-the-progression-and-cisplatin-resis-peer-reviewed-fulltext-article-CMAR |
work_keys_str_mv | AT wangy lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction AT wangx lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction AT hanl lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction AT hud lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction |